Metal oxide nanozymes are emerging as robust redox catalysts, yet the molecular basis of their substrate selectivity and reaction pathways remains poorly understood. Here, we identify 20 mol% Mn-doped TiO2 as a nanozyme platform that selectively oxidizes aromatic amino acids through a surface-confined pathway distinct from conventional diffusible radical-mediated oxidation. Using tyrosine, histidine, and phenylalanine together with 13C/15N isotopically labeled analogues, we combined high-resolution NMR spectroscopy, LC-MS/MS, X-ray photoelectron spectroscopy, and density functional theory calculations to resolve the underlying reaction mechanism. The data show that substrate oxidation proceeds through direct coordination to Mn-modified surface sites, followed by oxidative deamination, Cα–Cβ bond cleavage, and decarboxylation to yield the corresponding aldehydes: 4-hydroxybenzaldehyde, 1H-imidazole-4-carbaldehyde, and benzaldehyde. Isotopic labeling establishes that this transformation follows a Strecker-type degradation pathway localized at the nanozyme interface. XPS analysis demonstrates preservation of the Mn surface redox profile during catalysis, consistent with reversible Mn(III)/Mn(IV) cycling within the TiO2 lattice. Computational modeling further supports the thermodynamic feasibility of sequential proton-coupled electron-transfer steps leading to oxidative fragmentation. These findings establish that Mn doping programs TiO2 surfaces for selective dehydrogenase-like reactivity, through surface-directed interfacial oxidation, distinct from conventional diffusible radical-mediated pathways. The results provide a framework for rationally engineering metal oxide nanozymes with enzyme-like selectivity for targeted biomolecular transformations.
No takes yet. Share an insight, caveat, or question.
Kozlowski et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: